The findings revealed that both SLC30A9 mRNA and protein levels were significantly increased in primary human cervical cancer cells (“pCCa-1,” “pCCa-2,” and “pCCa-3”, derived from three patients) and the immortalized HeLa cell line (Fig. 1G, H). This evidence concerns the gene SLC30A9 and cervical cancer.